Spectranetics is planning a clinical trial of its Turbo Tandem and Turbo Elite laser ablation devices in the treatment of in-stent restenosis. The company plans to initiate a multicentre, randomised US trial of laser ablation followed by adjunctive balloon angioplasty in the treatment of in-stent ...
Please Login to read the full article.
